Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sánchez de la Torre, A. Barceló, M. De la Peña, S. Gómez, F. Capote, J. F. Masa, J. Durán, J. M. Marín, L. De Lecea, F. Barbé (Lleida, Madrid, Spain). Neuropeptide plasma levels in sleep apnea patients with and without excessive daytime sleepiness. Eur Respir J 2009; 34: Suppl. 53, 3692

Member's Comments

No comment yet.

Related content which might interest you: Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Ghrelin, leptin and adiponectin plasma levels in sleep apnea patients with and without excessive daytime sleepiness Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007 Diagnosing excessive daytime sleepiness in obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019 Daytime sleepiness in patients with treated obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 594s Year: 2007 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Source: Eur Respir J 2011; 37: 98-105 Year: 2011 Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 17: 838-847 Year: 2001 Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Evaluation of variables related with sympathetic activity in obstructive sleep apnea patients with and without excessive daytime sleepiness Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Daytime sleepiness and polysomnographic variables in sleep apnoea patients Source: Eur Respir J 2007; 30: 110-113 Year: 2007 Excessive daytime sleepiness in patients with sleep-disordered breathing Source: Eur Respir J 2008; 31: 685-686 Year: 2008 Daytime sleepiness and quality of life in patients with obstructive sleep apnea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019